Developing and validating our 16-pathogen Cannabis Pathogen focus panel requires rigorous validation to ensure specificity and sensitivity. This white paper describes the Verne Bio’s team validation of our protocol that is a multiplex qPCR assay based on our patent pending 4D-qPCR technology.